Cipla Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Mid Cap

Cipla has allotted 35,106 fully paid-up equity shares of Rs 2 each, pursuant to exercise of employee stock options / stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.

Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 1,61,51,06,210 comprising of 80,75,53,105 equity shares of face value Rs 2 each.

Powered by Capital Market - Live News

Cipla will hold a meeting of the Board of Directors of the Company on 26 July 2024.

Powered by Capital Market - Live News

Cipla Ltd fell for a fifth straight session today. The stock is quoting at Rs 1499.25, down 0.34% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.6% on the day, quoting at 23679.75. The Sensex is at 77916.26, up 0.74%.Cipla Ltd has gained around 1.39% in last one month.Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has increased around 2.02% in last one month and is currently quoting at 19521.15, down 0.12% on the day. The volume in the stock stood at 8.03 lakh shares today, compared to the daily average of 18.08 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 1499.9, down 0.46% on the day. Cipla Ltd jumped 46.71% in last one year as compared to a 26.69% rally in NIFTY and a 45.63% spurt in the Nifty Pharma index.

The PE of the stock is 32.68 based on TTM earnings ending March 24.

Powered by Capital Market - Live News

Cipla announced that the United States Food and Drug Administration (USFDA) vide communication dated 25 June 2024 has classified the inspection of the company's manufacturing facility in Patalganga as Voluntary Action Indicated (VAI).

Powered by Capital Market - Live News